Movie Industry

A single ticket for "Yong-A-Maek" costs 200,000 won... but movie tickets are excluded from the law against scalping

The Movie 'Blind Spot,' a Pop Culture Consumer Product Amendment Proposed, but It’s Taking a Nap in the National Assembly

Choi Hee-jae
2026-08-28 06:00:05
[E-Daily Starin Choi Hee-jae Reporter] While a law punishing the resale of tickets for live performances and sporting events is taking effect, critics point out that movies—a prime example of popular culture consumption—remain in a regulatory blind spot.
On the morning of the 23rd, as the movie "Odyssey" nears the 7 million viewer mark, a promotional video for the film is playing at a movie theater in Seoul. (Photo = News1)

Starting on the 28th, the so-called “Scalping Prevention Act” (Performance Act and National Sports Promotion Act) will go into full effect. Penalties will be significantly strengthened; for example, those caught illegally selling tickets for performances or professional sports events will face fines of up to 50 times the sale price. However, movie theater tickets are excluded from the scope of this law.
With demand for special screening theaters rising due to recent blockbuster hits, the issue of movie scalping has resurfaced. On the 24th, tickets for the “Yong-A-Max” (CGV Yongsan I’Park Mall IMAX) screening of the movie “The Odyssey” were listed for sale on the secondhand ticket trading platform TicketBay at up to 200,000 won per ticket. This is a whopping 10 times the face value (20,000 won).
CGV stated, “Tickets purchased through unauthorized channels may be canceled without prior notice,” and has launched its own crackdown. The Korean Film Council (KOFIC) has also been accepting reports of scalping and illegal transactions involving special-format screenings since the 18th. According to KOFIC, 391 reports of scalping and illegal transactions were received over the six-day period from the 19th to the 25th.

On the 25th, IMAX tickets for the movie “The Odyssey” were being sold for 200,000 won each on the secondhand ticket trading platform TicketBay. (Photo: Screenshot from TicketBay)

A bill to address this issue has already been proposed in the National Assembly. The “Partial Amendment to the Act on the Promotion of Movies and Videotapes,” sponsored by Democratic Party of Korea Representative Kim Jun-hyuk on November 6, 2024, includes provisions prohibiting and imposing sanctions on the resale of movie tickets at prices higher than the face value or the facilitation of such resales. However, the bill has been pending for one year and nine months without completing the legislative process.
Voices within the film industry are calling for movie tickets to be brought out of the regulatory blind spot, given that regulations on scalping for live performances and sports events are being strengthened. An industry official stated, “Even if scalpers are caught, the measures available under current law—such as imposing administrative fines or penalties—are limited,” adding, “We urgently need mechanisms to effectively manage and oversee this issue within the legal framework.”

Economy

Corporation

IT·Science

Economy

Shifting from Short-Term to Medium- and Long-Term... Appeal of Commercial Paper as a Funding Source Plummets

Fluctuations in credit spreads serve as an indicator of investor sentiment and capital flows in the corporate bond market. “Credit Signal” provides an intuitive analysis of the market’s overall trends…
2026-10-23 17:57:04

Corporation

Jeong Yong-jin Starts by Replacing E-MART Co., Ltd.’s CEO… Appoints Entire Executive Team in Their 40s

Shinsegae Co.,Ltd Chairman Chung Yong-jin is returning to the forefront of management at E-MART Co., Ltd.(139480). Unlike in 2013, when he stepped down as a registered director and entrusted the busin…
2026-10-23 14:55:06

IT·Science

HANALL BIOPHARMA CO.,LTD’s ‘Batoclimab’ Receives First New Drug Approval in China Nine Years After Technology Export

“Batoclimab,” a treatment for autoimmune diseases developed by HANALL BIOPHARMA CO.,LTD(009420), has received new drug approval in China. This comes approximately nine years after the company licensed…
2026-10-23 21:05:02